Dajani A S, Taubert K A, Takahashi M, Bierman F Z, Freed M D, Ferrieri P, Gerber M, Shulman S T, Karchmer A W, Wilson W
Office of Scientific Affairs, American Heart Association, Dallas, TX 75231-4596.
Circulation. 1994 Feb;89(2):916-22. doi: 10.1161/01.cir.89.2.916.
Long-term management of patients with Kawasaki disease should be tailored to the degree of coronary arterial involvement. This committee has made recommendations for each risk level about antiplatelet and anticoagulant therapy, physical activity, follow-up assessment by a pediatric cardiologist or primary care physician, and the appropriate diagnostic procedures that may be performed to evaluate cardiac disease. The risk level for a given patient with coronary arterial involvement may change over time because of changes in coronary artery morphology. The recommendations for management presented here are intended as practical interim guidelines until additional prospective or retrospective data are compiled to define more clearly the natural history of Kawasaki disease.
川崎病患者的长期管理应根据冠状动脉受累程度进行调整。本委员会已针对每个风险水平就抗血小板和抗凝治疗、体育活动、由儿科心脏病专家或初级保健医生进行的随访评估以及为评估心脏疾病可能进行的适当诊断程序提出了建议。由于冠状动脉形态的变化,特定冠状动脉受累患者的风险水平可能会随时间而改变。此处提出的管理建议旨在作为实用的临时指南,直至收集到更多前瞻性或回顾性数据以更清楚地界定川崎病的自然病程。